[1] Whicher CA,O'Neill S,Holt RIG .2020 .. Diabetes in the UK: 2019. Diabet Med, 10(2) : 242-7.
[2] Nomura A,Noguchi M,Kometani M,Furukawa K,Yoneda T. .2021 .Artificial intelligence in current diabetes management and prediction. Curr Diab Rep, 10(12) : 61.
[3] Kasim S,Al‐Dabbagh B,Mustafa Y. .2022 .A review on the biological potentials of carbazole and its derived products. J Med Pharm Chem Res, 4(6) : 495-512.
[4] Sagoo MK,Gnudi L .2067 .Diabetic nephropathy: An overview. Methods Mol Biol, 10(8) : 1-7.
[5] Opazo-Ríos L,Mas S,Marín-Royo G,Mezzano S,Gómez-Guerrero C,Moreno JA .2020 .Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities. Int J Mol Sci, 10(7) : 2632.
[6] Kolarić V,Svirčević V,Bijuk R,Zupančič V .2022 .Chronic complications of diabetes and quality of life. Acta Clin Croat, 61(3) : 520-7.
[7] Harreiter J,Roden M. .2023 .Diabetes mellitus: Definition, classification, diagnosis, screening and prevention (. doi:10, 135(Suppl 1) : 7-17.
[8] Ma CX,Ma XN,Guan CH,Li YD,Mauricio D,Fu SB .2022 .Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management. Cardiovasc Diabetol, 10(1) : 74.
[9] Kiss LZ,Bagyura Z,Vadas R,Polgár L,Lux Á,Édes E .2017 .Signs of subclinical atherosclerosis in asymptomatic patients at increased risk of type 2 diabetes mellitus. J Diabetes Complications, 05(8) : 1293-8.
[10] Dulyapach K,Ngamchaliew P,Vichitkunakorn P,Sornsenee P,Choomalee K. .2022 .Prevalence and associated factors of delayed diagnosis of type 2 diabetes mellitus in a tertiary hospital: A retrospective cohort study. Int J Public Health, 10 : 1605039.
[11] Zhou Z,Sun B,Yu D,Zhu C .2022 .Gut microbiota: An important player in type 2 diabetes mellitus. Front Cell Infect Microbiol, 10 : 834485.
[12] Creţu D,Cernea S,Onea CR,Pop RM .2020 .Reproductive health in women with type 2 diabetes mellitus. Hormones (Athens), 10(3) : 291-300.
[13] Boucsein A,Kamstra K,Tups A .2021 .Central signaling cross-talk between insulin and leptin in glucose and energy homeostasis. J Neuroendocrinol, 10(4) : .
[14] Amjad Hashim H,Al-Shammaa NMJ .2022 .The role of Irisin level hormone and some biochemical parameters in Iraqi diabetic type 2 with hypothyroidism. J Med Pharm Chem Res, 4(9) : 900-9.
[15] Vatier C,Jéru I,Fellahi S,Capeau J,Bastard JP,Vigouroux C .2020 .Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes. doi:10, 78(3) : 261-4.
[16] Russo B,Menduni M,Borboni P,Picconi F,Frontoni S. .2021 .Autonomic nervous system in obesity and insulin-resistance-the complex interplay between leptin and central nervous system. Int J Mol Sci, 10(10) : 5187.
[17] Hong S,Shinya Y,Trejo-Lopez JA,Gruber LM,Erickson D,Bendok BR .2023 .The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation. Clin Neurol Neurosurg, 10 : 108075.
[18] Prévot V,Tena-Sempere M,Pitteloud N M .2023 .New horizons: Gonadotropin-releasing hormone and cognition. J Clin Endocrinol Metab, 10(11) : 2747-58.
[19] Sadovoy VV,Selimov M,Shchedrina T,Nagdalian AA .1843 .Nutritional supplement for control of diabetes. J Excip Food Chem, 8352017 : .
[20] Ferreira-Hermosillo A,de Miguel Ibañez R,Pérez-Dionisio EK,Villalobos-Mata KA .2023 .Obesity as a neuroendocrine disorder. Arch Med Res, 10(8) : 102896.
[21] Murray SL,Holton KF .2021 .Post-traumatic stress disorder may set the neurobiological stage for eating disorders: A focus on glutamatergic dysfunction. Appetite, 10 : 105599.
[22] Cascino G,Monteleone AM .2023 .Early traumatic experiences and the hypothalamus-pituitary-adrenal axis in people with eating disorders: A narrative review. Psychoneuroendocrinology, 10 : 106665.
[23] Nauck MA,Wefers J,Meier JJ .2021 .Treatment of type 2 diabetes: Challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol, 8587(21) : 00113-3.
[24] Sadovoy VV,Selimov MA,Slichedrina TV,Nagdalian AA .2016 .Usage of biological active supplements in technology of prophilactic meat products. Res J Pharm Biol Chem Sci, 7(5) : 1861-5.
[25] Lyashenko EN,Uzbekova LD,Polovinkina VV,Dorofeeva AK,Ibragimov SS,Tatamov AA .2023 .Study of the embryonic toxicity of TiO2 and ZrO2 nanoparticles. Micromachines (Basel), 10(2) : 363.
[26] Verevkina M,Goncharov V,Nesmeyanov E,Kamalova O,Baklanov I,Pokhilko A,Potr S J Food Sci A .2023 .Application of the Se NPs-Chitosan molecular complex for the correction of selenium deficiency in rats model. , 10(1) : 455-66.
[27] Belyaev NG,Rzhepakovsky IV,Timchenko LD,Areshidze DA,Simonov AN,Nagdalian AA .2019 .Effect of training on femur mineral density of rats. Biochem Cell Arch, 19(2) : 3549-52.
[28] El Sadik A,Alrehaili J,Elzainy A .2024 .Comparison of the therapeutic role of sublethal doses of selenium nanoparticles in renal inflammation and apoptosis. J Med Pharm Chem Res, 453230(11) : 1725-39.
[29] Amalia A,Hendarto H,Mustika A .2024 .GDF-9 expression, apoptosis expression, and ovarian follicles. J Med Pharm Chem Res, 444235(7) : 997-1009.
[30] Salemkour Y,Yildiz D,Dionet L,t Hart DC,Verheijden KAT,Saito R .2023 .Podocyte injury in diabetic kidney disease in mouse models involves TRPC6-mediated calpain activation impairing autophagy. J Am Soc Nephrol, 10(11) : 1823-42.
[31] Pugliese G,Penno G,Natali A,Barutta F,Di Paolo S,Reboldi G .2019 .Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian diabetes society and the Italian society of nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function". Nutr Metab Cardiovasc Dis, 07(11) : 1127-50.
[32] Jia G,Sowers JR .2021 .Hypertension in diabetes: An update of basic mechanisms and clinical disease. Hypertension, 10(5) : 1197-205.